title: Choroidal neovascularization and bevacizumab therapy in Aicardi syndrome.
authors.forename: Adam S
authors.initials: AS
authors.lastname: Wenick
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Paskowitz
authors.forename: M Zain
authors.initials: MZ
authors.lastname: Tauqir
authors.forename: Quan Dong
authors.initials: QD
authors.lastname: Nguyen
mesh_terms: D058540:Aicardi Syndrome / Q000150:complications* / Q000175:diagnosis; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007223:Infant; D058449:Intravitreal Injections; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab